Operating, investing and financing flows differ from the reported change in cash by 109000000, beyond tolerance 31750000.00.
CARDINAL HEALTH INC (CAH) reported revenue of $254.25B and net income of $1.71B for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from CARDINAL HEALTH INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Wholesale-Drugs, Proprietaries & Druggists' Sundries.
Income
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B | $162.47B | $152.92B | $145.53B | $136.81B | $129.98B |
| Cost of revenue | $244.47B | $214.41B | $219.41B | $198.10B | $174.84B | $155.69B | $146.05B | $138.70B | $129.63B | $123.43B |
| Gross profit | $9.77B | $8.17B | $7.41B | $6.87B | $6.48B | $6.78B | $6.87B | $6.83B | $7.18B | $6.54B |
| Operating income | $2.61B | $2.28B | $1.24B | $752.00M | -$607.00M | $472.00M | -$4.10B | $2.06B | $126.00M | $2.12B |
| Net income | $1.71B | $1.56B | $852.00M | $330.00M | -$938.00M | $611.00M | -$3.70B | $1.36B | $256.00M | $1.29B |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 237.00M | shares 242.00M | shares 247.00M | shares 262.00M | shares 279.00M | shares 294.00M | shares 293.00M | shares 301.00M | shares 315.00M | shares 320.00M |
| Pretax income | $2.17B | $2.10B | $1.20B | $663.00M | -$784.00M | $323.00M | -$3.77B | $1.75B | -$228.00M | $1.92B |
| Income tax expense | $469.00M | $532.00M | $348.00M | $332.00M | $153.00M | -$289.00M | -$79.00M | $386.00M | -$487.00M | $630.00M |
| Diluted EPS | $7.23 | $6.45 | $3.45 | $1.26 | $-3.37 | $2.08 | $-12.61 | $4.53 | $0.81 | $4.03 |
| Selling, general & administrative | $6.13B | $5.38B | $5.00B | $4.80B | $4.51B | $4.53B | $4.57B | $4.48B | $4.60B | $3.78B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4.86B | $3.87B | $5.13B | $4.08B | $4.72B | $3.41B | $2.77B | $2.53B | $1.76B | $6.88B |
| Total assets | $57.30B | $53.12B | $45.12B | $43.35B | $43.88B | $44.45B | $40.77B | $40.96B | $39.95B | $40.11B |
| Current assets | $38.75B | $36.37B | $34.88B | $33.74B | $32.94B | $31.05B | $25.94B | $25.75B | $24.55B | $28.34B |
| Total liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current liabilities | $43.90B | $38.90B | $35.64B | $33.74B | $30.55B | $27.62B | $23.62B | $24.11B | $22.89B | $21.22B |
| Total equity incl. NCI | -$2.72B | -$2.63B | -$3.21B | -$2.96B | -$882.00M | $1.62B | $1.79B | $6.33B | $6.06B | $6.83B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $0 | $12.00M | $118.00M |
| Inventory | $17.30B | $16.83B | $14.96B | $16.12B | $15.64B | $14.59B | $13.20B | $12.82B | $12.31B | $11.30B |
| Accounts receivable | $13.82B | $13.24B | $12.08B | $11.11B | $10.56B | $9.10B | $8.26B | $8.45B | $7.80B | $8.05B |
| Goodwill | $11.44B | $9.69B | $4.72B | $4.61B | $5.86B | $7.99B | $8.36B | $8.38B | $8.32B | $7.22B |
| Long-term debt | $7.00B | $7.98B | $4.66B | $3.91B | $4.74B | $5.36B | $6.76B | $7.58B | $8.01B | $9.07B |
| Accounts payable | $38.28B | $34.71B | $31.76B | $29.93B | $27.13B | $23.70B | $21.37B | $21.54B | $19.68B | $17.91B |
Cash flow
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.17B | $2.40B | $3.76B | $2.84B | $3.18B | $2.43B | $1.96B | $2.72B | $2.77B | $1.18B |
| Capital expenditures | $649.00M | $547.00M | $511.00M | $481.00M | $387.00M | $400.00M | $375.00M | $328.00M | $384.00M | $387.00M |
| Investing cash flow | -$2.58B | -$5.59B | -$1.85B | -$454.00M | $567.00M | -$378.00M | $493.00M | $338.00M | -$5.61B | -$405.00M |
| Financing cash flow | -$1.60B | $1.94B | -$847.00M | -$3.05B | -$2.46B | -$1.32B | -$2.20B | -$2.29B | -$2.28B | $3.75B |
| Net change in cash | $982.00M | -$1.26B | $1.06B | -$669.00M | $1.36B | $636.00M | $240.00M | $768.00M | -$5.12B | $4.52B |
| Stock-based compensation | $367.00M | $244.00M | $121.00M | $96.00M | $81.00M | $89.00M | $90.00M | $82.00M | $85.00M | $96.00M |
| Common dividends paid | $491.00M | $494.00M | $499.00M | $525.00M | $559.00M | $573.00M | $569.00M | $577.00M | $581.00M | $577.00M |
| Common share repurchases | $1.36B | $765.00M | $750.00M | $2.00B | $1.00B | $200.00M | $350.00M | $600.00M | $550.00M | $600.00M |
| Depreciation & amortization | $956.00M | $790.00M | $710.00M | $692.00M | $692.00M | $783.00M | $913.00M | $1.00B | $1.03B | $717.00M |
Derived
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $4.52B | $1.85B | $3.25B | $2.36B | $2.79B | $2.03B | $1.58B | $2.39B | $2.38B | $797.00M |
| Gross margin | 3.8% | 3.7% | 3.3% | 3.4% | 3.6% | 4.2% | 4.5% | 4.7% | 5.2% | 5.0% |
| Operating margin | 1.0% | 1.0% | 0.5% | 0.4% | -0.3% | 0.3% | -2.7% | 1.4% | 0.1% | 1.6% |
| FCF margin | 1.8% | 0.8% | 1.4% | 1.2% | 1.5% | 1.2% | 1.0% | 1.6% | 1.7% | 0.6% |
| SBC / revenue | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Current ratio | 0.88x | 0.94x | 0.98x | 1.00x | 1.08x | 1.12x | 1.10x | 1.07x | 1.07x | 1.34x |
| Revenue YoY growth | 14.2% | -1.9% | 10.7% | 13.0% | 11.6% | 6.2% | 5.1% | 6.4% | 5.3% | Unavailable |
| Net margin | 0.7% | 0.7% | 0.4% | 0.2% | -0.5% | 0.4% | -2.4% | 0.9% | 0.2% | 1.0% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | 0.3% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 21.6% | 25.3% | 29.0% | 50.1% | Unavailable | -89.5% | Unavailable | 22.0% | Unavailable | 32.7% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CAH in the interactive workspace to inspect any figure back to its filing.
Source filings
Reconciliation checks needing review
2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
Operating, investing and financing flows differ from the reported change in cash by 109000000, beyond tolerance 24290000.00.